We are live on ! Find out more
MC

Mathes Company Portfolio holdings

AUM $274M
1-Year Est. Return 33.72%
This Fund
S&P 500
This Quarter Est. Return
+4.16%
1 Year Est. Return
+33.72%
3 Year Est. Return
+105.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$274M
AUM Growth
-$9.44M
Cap. Flow
-$18.1M
Cap. Flow %
-6.6%
Top 10 Hldgs %
36.68%
Holding
129
New
2
Increased
8
Reduced
53
Closed
5

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.61M
2
LLY icon
Eli Lilly
LLY
+$464K
3
TTD icon
Trade Desk
TTD
+$247K
4
BCAT icon
BlackRock Capital Allocation Term Trust
BCAT
+$214K
5
IGV icon
iShares Expanded Tech-Software Sector ETF
IGV
+$109K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$2.54M
2
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
+$2.12M
3
IHI icon
iShares US Medical Devices ETF
IHI
+$2.03M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$1.35M
5
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 15.87%
2 Industrials 15.07%
3 Financials 7.41%
4 Communication Services 5.78%
5 Consumer Staples 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
126
Freeport-McMoran
FCX
$90.3B
– –
-4,300
Closed -$215K
NVO
127
Novo Nordisk
NVO
$205B
– –
-4,191
Closed -$499K
USB.PRR icon
128
US Bancorp Series M Preferred Stock
USB.PRR
$458M
– –
-24,575
Closed -$485K
2 3 4 5
6

Similar funds

SN
Sittner & Nelson Eugene, Oregon $274M AUM 22.46% 1-Year Est. Return
OL
Odyssean LLC Darien, Connecticut $274M AUM
JWM
Jessup Wealth Management Dayton, Ohio $274M AUM 29.44% 1-Year Est. Return
MP
Maestria Partners Atlanta, Georgia $274M AUM 13.12% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
PP
Praetorian PR Rincon, Puerto Rico $275M AUM 84.95% 1-Year Est. Return

Mathes Company's Q4 2024 Portfolio in Review

As of Q4 2024, Mathes Company held 129 positions worth $274M, down 3.3% from $283M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mathes Company withdrew a net $18.1M in Q4 2024, closing 5 positions and reducing 53 holdings. Its most notable exit was Novo Nordisk, an estimated $499K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

Against the trend, Mathes Company opened a new position in Eli Lilly worth $432K.

  • Mathes Company's largest Q4 2024 buy was Eli Lilly: 560 shares worth $432K.
  • Mathes Company added most to Procter & Gamble in Q4 2024, an estimated $3.61M increase.
  • Mathes Company's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $2.54M.
  • Mathes Company fully exited Novo Nordisk in Q4 2024, selling an estimated $499K.
  • Mathes Company's ten largest holdings make up 37% of its $274M portfolio in Q4 2024.
  • Mathes Company opened 2 new positions and closed 5 in Q4 2024.
  • Mathes Company's portfolio value fell 3.3% quarter-over-quarter to $274M.

Based on Mathes Company's 13F filing for Q4 2024, filed 31 Jan 2025.